114 Per Cent Returns: Multibagger Pharma Company Reports 81 Per Cent PAT Growth; Sales Up 9 Per Cent 114 Per Cent Returns: Multibagger Pharma Company Reports 81 Per Cent PAT Growth; Sales Up 9 Per Cent The company's net profit surged 81 per cent year-on-year (YoY) to Rs 276.4 crore, compared to Rs 152.9 crore in Q3 FY24. Manoj Reddy Sama / Thursday, February 13, 2025 0 266 Article rating: 3.8 Revenue grew by 9 per cent YoY to Rs 2,245.4 crore, up from Rs 2,052.9 crore in the corresponding quarter last year. Read more
900 Percent Returns: Multibagger Specialty Chemical Company Reports Highest-Ever EBITDA, PAT Growth at 31 Per Cent 900 Percent Returns: Multibagger Specialty Chemical Company Reports Highest-Ever EBITDA, PAT Growth at 31 Per Cent Profit after tax (PAT) witnessed significant growth, rising by 31.48 per cent YoY to approximately Rs 142 crore in Q3 FY25, compared to Rs 108 crore in Q3 FY24. Manoj Reddy Sama / Tuesday, January 14, 2025 0 860 Article rating: 4.0 For the nine-month period ending December 2024, Himadri recorded a 24 per cent increase in sales volumes, reaching 415,679 metric tons (MT), up from 335,265 MT during the same period last year. Read more
Morbis temporary shutdown turns fruitful for other ceramic stocks as five turn multibaggers; Pokarna emerges as top gainer! Morbis temporary shutdown turns fruitful for other ceramic stocks as five turn multibaggers; Pokarna emerges as top gainer! Morbi’s yearly turnover is approximately Rs 50,000 crore while its yearly export is about Rs 15,000 crore. The only biggest competitor of Morbi in the world is China Karan Dsij / Sunday, July 31, 2022 1 7695 Article rating: 3.9 Interestingly, if we look at the CY2022 performance of Pokarna and Orient Bell, the stock of Orient Bell jumped nearly 92 per cent in CY2022 whereas Pokarna unperformed Orient Bell by a wide margin as it delivered negative returns! Read more